A citation-based method for searching scientific literature

Patrick J Killela, Zachary J Reitman, Yuchen Jiao, Chetan Bettegowda, Nishant Agrawal, Luis A Diaz, Allan H Friedman, Henry Friedman, Gary L Gallia, Beppino C Giovanella, Arthur P Grollman, Tong-Chuan He, Yiping He, Ralph H Hruban, George I Jallo, Nils Mandahl, Alan K Meeker, Fredrik Mertens, George J Netto, B Ahmed Rasheed, Gregory J Riggins, Thomas A Rosenquist, Mark Schiffman, Ie-Ming Shih, Dan Theodorescu, Michael S Torbenson, Victor E Velculescu, Tian-Li Wang, Nicolas Wentzensen, Laura D Wood, Ming Zhang, Roger E McLendon, Darell D Bigner, Kenneth W Kinzler, Bert Vogelstein, Nickolas Papadopoulos, Hai Yan. Proc Natl Acad Sci U S A 2013
Times Cited: 841



Rachel Litman Flynn, Kelli E Cox, Maya Jeitany, Hiroaki Wakimoto, Alysia R Bryll, Neil J Ganem, Francesca Bersani, Jose R Pineda, Mario L Suvà, Cyril H Benes, Daniel A Haber, Francois D Boussin, Lee Zou. Science 2015
Times Cited: 241




List of shared articles



Times cited

Solid tumours hijack the histone variant network.
Flávia G Ghiraldini, Dan Filipescu, Emily Bernstein. Nat Rev Cancer 2021
2

Alternative lengthening of telomeres in molecular subgroups of paediatric high-grade glioma.
Simone Minasi, Caterina Baldi, Francesca Gianno, Manila Antonelli, Anna Maria Buccoliero, Torsten Pietsch, Maura Massimino, Francesca Romana Buttarelli. Childs Nerv Syst 2021
1

Telomeres: history, health, and hallmarks of aging.
Deepavali Chakravarti, Kyle A LaBella, Ronald A DePinho. Cell 2021
6

ALT Positivity in Human Cancers: Prevalence and Clinical Insights.
Danny MacKenzie, Andrea K Watters, Julie T To, Melody W Young, Jonathan Muratori, Marni H Wilkoff, Rita G Abraham, Maria M Plummer, Dong Zhang. Cancers (Basel) 2021
0

Telomere-related Markers for Cancer.
Xiaotian Yuan, Mingkai Dai, Dawei Xu. Curr Top Med Chem 2020
10

Correlation between IDH, ATRX, and TERT promoter mutations in glioma.
Shigeo Ohba, Kiyonori Kuwahara, Seiji Yamada, Masato Abe, Yuichi Hirose. Brain Tumor Pathol 2020
5

Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma.
Balakrishna Koneru, Gonzalo Lopez, Ahsan Farooqi, Karina L Conkrite, Thinh H Nguyen, Shawn J Macha, Apexa Modi, Jo Lynne Rokita, Eduardo Urias, Ashly Hindle,[...]. Cancer Res 2020
11